Skip to main content
. 2006 Jan 17;94(2):253–258. doi: 10.1038/sj.bjc.6602932

Figure 2.

Figure 2

Higher expression of both survivin (A and B) and COX-2 (C) were associated with increased cumulative 5-year recurrence. DCIS that expressed both COX-2 and HER2 (D) or COX-2 and survivin (E) had the poorest 5-year recurrence-free survival.